SiwenHu-LieskovanMD
Oncology • Salt Lake City, UTHematologic Oncology, Melanoma
Assistant Professor of Medicine
Dr. Hu-Lieskovan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1950 Circle of Hope Dr
Salt Lake City, UT 84112Phone+1 801-581-8793- Is this information wrong?
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2011 - 2014
University of Southern California/LAC+USC Medical CenterResidency, Internal Medicine, 2008 - 2011
China Medical University ShenyangClass of 1998
Certifications & Licensure
UT State Medical License 2018 - 2026
MT State Medical License 2022 - 2024
CO State Medical License 2022 - 2023
ID State Medical License 2022 - 2023
NV State Medical License 2022 - 2023
WY State Medical License 2022 - 2023
CA State Medical License 2010 - 2020
Awards, Honors, & Recognition
- Melanoma Research Alliance YIA 2017
- SU2C/AACR Phillip A. Sharp Innovation in Collaboration Award 2017
- Danial D. Von Hoff Innovative Protocol Award AACR/ASCO MCCR Workshop, 2015
- Join now to see all
Clinical Trials
- Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566 Start of enrollment: 2015 Apr 23
- A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors Start of enrollment: 2015 Jul 02
- Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1 Start of enrollment: 2017 Jan 03
- Join now to see all
Publications & Presentations
PubMed
- Exploring the Landscape of Immune Checkpoint Inhibitor-Induced Adverse Events Through Big Data Mining of Pan-Cancer Clinical Trials.Muhammad Zaki Hidayatullah Fadlullah, Ching-Nung Lin, Samuel Coleman, Arabella Young, Abdul Rafeh Naqash, Siwen Hu-Lieskovan, Aik Choon Tan> ;The Oncologist. 2024 May 3
- Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4naïve T cells at baseline are associated with severe immune-related advers...Kovacsovics-Bankowski, M., Sweere, J., Healy, C., Sigal, N., Cheng, L., Chronister, W., Evans, S., Marsiglio, J., Gibson, B., Swami, U., Erickson-Wayman, A., McPherson...> ;Journal for Immunotherapy of Cancer. 2024 Jan 17
- 1 citationsComparing the rate of immunotherapy treatment change due to toxicity by sex.Chua, K., Liu, H., Schneider, B., Sterling, J., Singer, E., Kronstedt, S., Kaldany, A., Srivastava, A., Tarhini, A., Gatti-Mays, M., Gaughan, E., Hu-Lieskovan, S., Alj...> ;Cancer Reports. 2024 Feb 1
- Join now to see all
Journal Articles
- Prognostic Gene Expression Profiling in Cutaneous MelanomaDouglas Grossman, Sancy A Leachman, Larissa Korde, Elizabeth I Buchbinder, Emily Y Chu, Julia A Curtis, Laura K Ferris, Kenneth F Grossmann, Siwen Hu-Lieskovan, Joanne..., JAMA Dermatology
Lectures
- Heterogeneity of Resistant Mechanisms to PD-1 Checkpoint InhibitorsASCO Annual Meeting 2019 - Chicago, IL - 6/3/2019
- Reversing resistance to PD-1 blockade by combination of talimogene laherparepvec (T-VEC) with pembrolizumab (pembro) in advanced melanoma patients following progressio...2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
- Role of CD4 cells in the complete anti-tumor response to PD1 blockade in a syngeneic murine melanoma model with activated WNT signaling.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Authored Content
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
- Prognostic Gene Expression Profiling in Cutaneous MelanomaJuly 2020
Press Mentions
OncoC4 to Present Positive Data from Ongoing Phase 1/2 PRESERVE-001 Trial of ONC-392 in Combination with Pembrolizumab at SITC 2022November 7th, 2022
Immunotherapy Leads the Way for Melanoma TreatmentDecember 3rd, 2019
Adding a Vaccine to Immunotherapy in Lung Cancer: Will It Improve Outcomes?March 4th, 2019
Professional Memberships
- Member
- Member
- Southwest Oncology GroupMember
- Jonsson Comprehensive Cancer CenterMember
Other Languages
- Chinese (Mandarin)
Hospital Affiliations
University of Utah HealthSalt Lake City, Utah
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
